IL18 and small cell lung carcinoma: Low doses of SC16.8_IL18 CAR T cells were able to prolong survival or induce long-term responses in SCLC models with metastatic H82 and H69 tumors and orthotopic SHP-77 tumors (Supplemental Figure 4).